References
- WHO, World Health Organization. Vaccines against influenza: wHO position paper. Weekly Epidemiological Record. 2022 May 13 [accessed 2022 Jun 21]. https://www.who.int/publications-detail-redirect/who-wer9719-185-208.
- Melidou A, Ködmön C, Nahapetyan K, Kraus A, Alm E, Adlhoch C, Mooks P, Dave N, Carvalho C, Meslé M, et al. Influenza returns with a season dominated by clade 3c.2a1b.2a.2 A(H3N2) viruses, WHO European region, 2021/22. Euro Surveill. 2022;27(15):1. PII: 2200255. doi:10.2807/1560-7917.ES.2022.27.15.2200255.
- Australian Government Department of health. Australian influenza surveillance report - No 05 - fortnight ending 05 June 2022. Australia: Australian Government Department of Health; 2022. Report No: 05.
- Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, Nair H. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021;21(2):193–12. doi:10.1016/S1473-3099(20)30785-4.
- Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou X, Feng L. The incoming influenza season - China, the United Kingdom, and the United States, 2021-2022. China CDC Wkly. 2021;3:1039–45.
- Schaffer DeRoo S, Pudalov N, Fu L. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458–59. doi:10.1001/jama.2020.8711.
- WHO, World Health OrganizationVaccines against influenza WHO position paper — November 2012 = Note de synthèse de l’oms concernant les vaccins antigrippaux — novembre 2012. Wkly Epidemiol Rec. 2012 Nov 13 [accessed 2022 Apr 21];87:461–76 https://apps.who.int/iris/handle/10665/241993.
- Domnich A, Orsi A, Trombetta C, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals. 2022;15(3):322. doi:10.3390/ph15030322.
- Watson O, Barnsley G, Toor J, Hogan A, Winskill P, Ghani A. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;S1473-3099:00320–6.
- WHO, World Health Organization. Coadministration of seasonal inactivated influenza and COVID-19 vaccines: interim guidance. 2021 Oct 21 [accessed 2022 Apr 14]. https://apps.who.int/iris/handle/10665/346897.
- Santé publique, Sécurité de la chaine alimentaire et environnement, SPF Santé publique. Avis 9675 - vaccination simultanée COVID-19. 2021 Oct 7 [accessed 2022 Feb 7]. https://www.health.belgium.be/fr/avis-9675-vaccination-simultanee-covid-19.
- Del af Statens Serum Institut. Spørgsmål og svar om covid-19-vaccination. [accessed 2022 Feb 7]. https://covid19.ssi.dk/vaccination/sporgsmaal-og-svar.
- Finnish Institute, Finnish Institute for Health and Welfare (THL). New recommendations for coronavirus vaccinations – pregnant women may take a coronavirus vaccine if they wish - Press release - THL. Finland; [accessed 2022 Feb 7]. https://thl.fi/en/web/thlfi-en/-/new-recommendations-for-coronavirus-vaccinations-pregnant-women-may-take-a-coronavirus-vaccine-if-they-wish.
- HAS, Haute Autorité de Santé. Covid-19 et grippe: undefined HAS précise les conditions d’une co-administration des vaccins. 2021 Sept 27 [accessed 2022 Feb 7]. https://www.has-sante.fr/jcms/p_3288855/fr/covid-19-et-grippe-la-has-precise-les-conditions-d-une-co-administration-des-vaccins.
- RKI, Robert Koch Institut. STIKO-Empfehlung zur Koadministration von COVID-19-Impfstoffen und anderen Totimpfstoffen und die dazugehörige wissenschaftliche Begründung. Archiv. 2021 Sep 30 [accessed 2022 Feb 7]. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/39/Art_03.html#: :text=Wie%20das%20Epidemiologische%20Bulletin%2039,24.9.2021%20online%20vorab%20ver%C3%B6ffentlicht.
- Ministero de la Salute (IMH). Influenza e vaccinazione antinfluenzale. FAQ. 2021 Oct 4 [accessed 2022 Feb 7]. https://www.salute.gov.it/portale/influenza/dettaglioFaqInfluenza.jsp?lingua=italiano&id=103
- Ministerio de Sanidad. Preguntas y Respuestas Sobre la Vacunacion Frente a la Gripe. 2021 Oct [accessed 2022 Feb 07]. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/gripe/faq/docs/Preguntas_respuestas_gripe_ciudadanos_2021-2022.pdf.
- Office fédéral de la santé publique (OFSP) et Commission fédérale pour les vaccinations (CFV). Recommandations de vaccination avec des vaccins à ARNm contre le COVID-19 (état au 23.5.2022). Switzerland; 2022 May 23.
- UK Health Security Agency. In: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1102459/Greenbook-chapter-14a-4September22.pdf 28 02 2022. 2022 COVID-19: the green book, chapter 14a Sept 05.
- Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett S, Garstang J, Gbadamoshi L, Hallis B, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdox1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFlucov): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277–87. doi:10.1016/S0140-6736(21)02329-1.
- Toback S, Galiza E, Cosgrove C, Galloway J, Goodman A, Swift P, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):167–79. doi:10.1016/S2213-2600(21)00409-4.
- Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, Vaezjalali M, Hajikhani B. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med. 2021;8:681469.
- Sentinelles. Observed situation in general practice for the week 8 of the year 2022, from 02/21/2022 to 02/27/2022. 2022 May 27 [accessed 2022 May 27]. https://www.sentiweb.fr/5558.pdf.
- Santé publique France. Bulletin épidémiologique grippe, semaine 19. Saison 2021-2022. [accessed 2022 May 18]. https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/grippe/documents/bulletin-national/bulletin-epidemiologique-grippe-semaine-19.-saison-2021-2022.
- Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M, Andrews N, Ramsay M, Lopez Bernal J. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021;50(4):1124–33. doi:10.1093/ije/dyab081.
- Swets M, Russell C, Harrison E, Docherty A, Lone N, Girvan M, Hardwick H, Visser L, Openshaw P, Groeneveld G, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022;399:1463–64.
- Baker R, Park S, Yang W, Vecchi G, Metcalf C, Grenfell B. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547–53. doi:10.1073/pnas.2013182117.
- Haute Autorité de Santé. Stratégie de vaccination contre la Covid-19 – anticipation des scénarios possibles à l’automne 2022. 2022 May 25 [accessed: 2022 May 27]. https://www.has-sante.fr/jcms/p_3340479/fr/strategie-de-vaccination-contre-la-covid-19-anticipation-des-scenarios-possibles-a-l-automne-2022.
- Stefanizzi P, Martinelli A, Bianchi F, Migliore G, Tafuri S. Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs. Hum Vaccin Immunother. 2022;18(1):1–2. doi:10.1080/21645515.2021.2011652.
- Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, Shamseer L, Tetzlaff J, Akl E, Brennan S, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi:10.1186/s13643-021-01626-4.
- Izikson R, Brune D, Bolduc J, Bourron P, Fournier M, Moore T, Pandey A, Perez L, Sater N, Shrestha A, et al. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Lancet Respir Med. 2022;10:392–402.
- Domnich A, Grassi R, Fallani E, Spurio A, Bruzzone B, Panatto D, Marozzi B, Cambiaggi M, Vasco A, Orsi A, et al. Changes in attitudes and beliefs concerning vaccination and influenza vaccines between the first and second COVID-19 pandemic waves: a longitudinal study. Vaccines. 2021;9(9):1016. doi:10.3390/vaccines9091016.
- Domnich A, Grassi R, Fallani E, Ciccone R, Bruzzone B, Panatto D, Ferrari A, Salvatore M, Cambiaggi M, Vasco A, et al. Acceptance of COVID-19 and influenza vaccine co-administration: insights from a representative Italian survey. J Pers Med. 2022;12(2):139. doi:10.3390/jpm12020139.
- COVIGIE. [accessed 2022 May 31]. https://covigie.org/enquete-express/numero-5-resultat?liste=site-covigie.
- Ma L, Yang J, Zhang T, Han X, Huang Q, Yang Y, Feng L, Yang W, Wang C. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China. Hum Vaccin Immunother 18 5 . 2022:1–9.
- Hause A, Zhang B, Yue X, Marquez P, Myers T, Parker C, Gee J, Su J, Shimabukuro T, Shay D. Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022;5:e2222241.
- Hu C, Tang Y, Su Q, Lei Y, Cui W, Zhang Y, Zhou Y, Li X, Wang Z, Zhao Z. Public health measures during the COVID-19 pandemic reduce the spread of other respiratory infectious diseases. Front Public Health. 2021;9:771638.
- Beatty A, Peyser N, Butcher X, Cocohoba J, Lin F, Olgin J, Pletcher M, Marcus G. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. doi:10.1001/jamanetworkopen.2021.40364.
- WHO, World Health Organization. Wh 202127o flumart outputs. [accessed 2022 Apr 21]. http://www.who.int/flunet.
- ACIP. Timing and spacing guidelines for immunization. CDC. 2022 Apr 14. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html.
- Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, Jönsson B, Verhaegen J, Gaillat J, Christie P, et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis. 2000;31:444–50.
- Paudyal V, Fialová D, Henman M, Hazen A, Okuyan B, Lutters M, Cadogan C, da Costa F, Galfrascoli E, Pudritz Y, et al. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm. 2021;43(4):1139–48. doi:10.1007/s11096-021-01301-7.
- Kirkdale C, Nebout G, Taitel M, Rubin J, Jacinto I, Horta R, Megerlin F, Thornley T. Implementation of flu vaccination in community pharmacies: understanding the barriers and enablers. Ann Pharm Fr. 2017;75(1):9–16. doi:10.1016/j.pharma.2016.08.006.
- ECDC, European Centre for Disease Prevention and Control. COVID-19 vaccine tracker. [accessed 2022 May 25]. https://vaccinetracker.ecdc.europa.eu/public/extensions/covid-19/vaccine-tracker.html#uptake-tab.
- Ministère des solidarités et de la santé. Le Tableau de bord de la vaccination. [accessed 2022 May 25]. https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/le-tableau-de-bord-de-la-vaccination.
- Gilchrist S, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health. 2012;102(4):596–605. doi:10.2105/AJPH.2011.300512.